Herein, we investigate the function of FBXO22 to MLL-AF9-induced AML development using two strains of hematopoietic-specific Fbxo22 knockout mice and found that FBXO22 promotes leukemogenesis and contributes to LSC maintenance by targeting BACH1. The gene discussed is FBXO22; the disease is acute myeloid leukemia.